Naldebain and Video-assisted Thoracoscopic Surgery

• Status: Not yet recruiting
• Trial end date: 2023-05-07
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the postoperative analgesic effect of combined use of Naldebain® and thoracic paravertebral block in thoracoscopic surgery

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
• Treatments: Nalbuphine

Criteria

Inclusion Criteria:

• 1) Subject's age: 20~65 years old

• 2) American Society of Anesthesiologists (ASA) Physical Status classification: I~III

• 3) Patients who need postoperative pain relief due to thoracoscopic surgery

Exclusion Criteria:

• 1. The patient suffers from a communication disorder

• 2. The patient has coagulopathy

• 3. Sick with obvious heart, lung, liver or kidney disease

• 4. The patient's body mass index is less than 18.5 or greater than 35

• 5. Pregnant patients

• 6. Patients who took opioids for more than three weeks before surgery

• 7. Patients with contraindications to local anesthesia

• 8. Patients with a history of chronic pain

• 9. Patients with a history of drug allergy to Naldebain